PE anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M170_PE_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_CD11b_Antibody_IHC_031413
    Fixed whole mount mouse spleen was stained with Alexa Fluor® 488 F4/80 (red) (clone BM8), Brilliant Violet 421™ CD3ε (green) (clone 145-2C11), and PE CD11b (blue) (clone M1/70). Isotype controls at the same concentrations were used for the negative control. Cells were mounted in Prolong Gold and imaged with a Leica SP8 confocal. Image courtesy of Grzegorz Chodaczek and Zbigniew Mikulski at LIAI.
Compare all formats See PE spectral data See more IHC data...
Cat # Size Price Quantity Check Availability Save
101207 50 µg 50 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101208 200 µg 160 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/mL
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Verified

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wang L, et al. 2012. PLoS One. 7:e40056. PubMed
  2. Demers M, et al. 2012. Proc Natl Acad Sci U S A. 109:13076. PubMed
  3. Resende M, et al. 2013. J Immunol. 191:262. PubMed
  4. Li L, et al. 2014. J Immunol. 192:1034. PubMed
  5. Langhauser F, et al. 2014. Stroke. 45:1799. PubMed
  6. Hirako N, et al. 2014. PLoS One. 9:103282. PubMed
  7. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  8. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  9. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  10. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  11. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  12. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  13. Baruch K, et al. 2015. EMBO J. 34: 1816 - 1828. PubMed
  14. Koshida R, et al. 2015. Biochem Biophys Res Commun. 463: 109-115. PubMed
  15. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  16. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  17. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  18. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  19. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  20. Li L, et al. 2015. J Am Soc Nephrol. 26: 2183-2197. PubMed
  21. Price J, et al. 2015. Diabetes. 64: 3521 - 3531. PubMed
  22. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  23. Kan X, et al. 2015. Cardiovasc Res. 10.1093/cvr/cvv255. PubMed
  24. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  25. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
  26. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  27. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  28. Huang L, et al. 2016. J Biol Chem. 291: 6232 - 6244. PubMed
  29. Lei G, et al. 2016. Antimicrob Agents Chemother. 60: 1289 - 1297. PubMed
  30. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  31. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  32. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  33. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  34. K K, et al. 2016. Haematologica. 151159. PubMed
  35. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  36. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  37. Chida J, et al. 2020. PLoS Pathog. 16:e1008823. PubMed
  38. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  39. Moorlag SJCFM, et al. 2020. Cell Rep. 33:108387. PubMed
  40. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  41. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  42. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  43. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  44. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  45. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  46. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  47. Avalle L, et al. 2020. Mol Ther Methods Clin Dev. 0.793055556. PubMed
  48. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  49. Houben T, et al. 2020. J Pathol. 251:429. PubMed
  50. Zhou Q, et al. 2020. Nat Immunol. 1.393055556. PubMed
  51. Lin KH, et al. 2020. Nat Genet. 52:408. PubMed
  52. Cao DY, et al. 2020. J Biol Chem. 295:1369. PubMed
  53. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  54. Donley DW, et al. 2021. PLOS ONE. 16(5):e0250606. PubMed
  55. Wong PP, et al. 2020. Cell. 181(6):1346-1363.e21. PubMed
  56. Jard T, et al. 2020. Cell Stem Cell. 27(4):646-662.e7. PubMed
  57. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  58. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  59. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
  60. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  61. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  62. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  63. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  64. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  65. Sokol L, et al. 2021. STAR Protocols. 2(2):100489. PubMed
  66. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  67. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  68. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  69. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  70. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  71. Turkowski K, et al. 2017. Glia. 10.1002/glia.23234. PubMed
  72. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  73. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  74. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  75. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  76. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  77. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  78. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  79. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  80. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  81. Wu ZJ, et al. 2018. Int J Oncol. 52:1209. PubMed
  82. Zhang T, et al. 2018. PLoS One. 13:e0196571. PubMed
  83. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  84. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  85. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  86. Hengyou Weng et al. 2018. Cell stem cell. 22(2):191-205 . PubMed
  87. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  88. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  89. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  90. Abdel Malik R, et al. 2017. Circ Res. 120:99. PubMed
  91. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  92. Dougan M, et al. 2018. Cancer Immunol Res. 6:389. PubMed
  93. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  94. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  95. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  96. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  97. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  98. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  99. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  100. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  101. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  102. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  103. Murray C, et al. 2018. Lab Chip. 18:2396. PubMed
  104. He J, et al. 2019. J Clin Invest. 130. PubMed
  105. Minuesa G, et al. 2019. Nat Commun. 10:2691. PubMed
  106. Gomez–Ospina N, et al. 2019. Nat Commun. 3.225694444. PubMed
  107. Xiao G, et al. 2018. Cell. 173:470. PubMed
  108. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  109. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  110. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  111. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  112. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  113. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  114. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  115. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  116. Huang Y, et al. 2019. Cancer Cell. 35:677. PubMed
  117. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  118. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  119. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  120. Luong-Gardiol N, et al. 2019. Cancer Cell. 35:649. PubMed
  121. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  122. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  123. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  124. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  125. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  126. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  127. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  128. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  129. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  130. Llewellyn GN, et al. 2018. J Neurovirol. 24:192. PubMed
  131. Paraiso HC, et al. 2018. J Neuroinflammation. 0.694444444. PubMed
  132. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  133. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  134. He L, et al. 2019. iScience. 0.790972222. PubMed
  135. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  136. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  137. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  138. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  139. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  140. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  141. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  142. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  143. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  144. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  145. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  146. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  147. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  148. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  149. Nakaya M, et al. 2017. J Clin Invest. 127:383. PubMed
  150. Keshavarz M, et al. 2020. Virol J. 17:64. PubMed
  151. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  152. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  153. Zhang M, et al. 2019. Autophagy. 1.423611111. PubMed
  154. Fernando N, et al. 2020. Front Cell Dev Biol. 0.691666667. PubMed
  155. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  156. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  157. Xiao X, et al. 2020. J Hematol Oncol. 0.597222222. PubMed
  158. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  159. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  160. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  161. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  162. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  163. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  164. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  165. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  166. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  167. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  168. Schmidt C, et al. 2005. J Immunol. 175:2286. PubMed
  169. Tan S, et al. 2006. J Immunol. 176:2872. PubMed
  170. Mayo L, et al. 2008. J Immunol. 181:92. PubMed
  171. Staschke K, et al. 2009. J Immunol. 183:568. PubMed
  172. Elkabets M, et al. 2009. J Immunol. 182:4874. PubMed
RRID
AB_312790 (BioLegend Cat. No. 101207)
AB_312791 (BioLegend Cat. No. 101208)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC, IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, IHC-F, ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC, IHC-F, 3D IHC, SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC, 3D IHC
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC, ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, Block, Depletion, IHC-F, ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC, CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F, FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 03.14.2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse/human CD11b

  • Biotin anti-mouse/human CD11b

  • FITC anti-mouse/human CD11b

  • PE anti-mouse/human CD11b

  • PE/Cyanine5 anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b

  • PE/Cyanine7 anti-mouse/human CD11b

  • Alexa Fluor® 488 anti-mouse/human CD11b

  • Alexa Fluor® 647 anti-mouse/human CD11b

  • Alexa Fluor® 700 anti-mouse/human CD11b

  • Pacific Blue™ anti-mouse/human CD11b

  • APC/Cyanine7 anti-mouse/human CD11b

  • PerCP/Cyanine5.5 anti-mouse/human CD11b

  • PerCP anti-mouse/human CD11b

  • Brilliant Violet 421™ anti-mouse/human CD11b

  • Brilliant Violet 570™ anti-mouse/human CD11b

  • Brilliant Violet 605™ anti-mouse/human CD11b

  • Brilliant Violet 650™ anti-mouse/human CD11b

  • Brilliant Violet 711™ anti-mouse/human CD11b

  • Brilliant Violet 785™ anti-mouse/human CD11b

  • Brilliant Violet 510™ anti-mouse/human CD11b

  • Ultra-LEAF™ Purified anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse/human CD11b

  • PE/Dazzle™ 594 anti-mouse/human CD11b

  • APC/Fire™ 750 anti-mouse/human CD11b

  • TotalSeq™-A0014 anti-mouse/human CD11b

  • Brilliant Violet 750™ anti-mouse/human CD11b

  • TotalSeq™-B0014 anti-mouse/human CD11b

  • TotalSeq™-C0014 anti-mouse/human CD11b

  • Spark NIR™ 685 anti-mouse/human CD11b

  • PE/Fire™ 640 anti-mouse/human CD11b

  • Spark YG™ 593 anti-mouse/human CD11b

  • Spark YG™ 570 anti-mouse/human CD11b

  • PE/Fire™ 810 anti-mouse/human CD11b

  • APC/Fire™ 810 anti-mouse/human CD11b Antibody

  • Spark Blue™ 550 anti-mouse/human CD11b

  • Spark UV™ 387 anti-mouse/human CD11b

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account